Supplementary Figure S3 from BCL2 Inhibition Reveals a Dendritic Cell–Specific Immune Checkpoint That Controls Tumor Immunosurveillance

<p>Supplementary Figure S3 shows the increased DC maturation and activation upon BCL2 inhibition, and indicates that this effect is crucial for the enhancement of DC antigen cross presentation by BCL2 inhibitors.</p>